Cargando…
Trend of clinical trials of new drugs for rare diseases in China in recent 10 years
BACKGROUND: Rare disease is a general term for a disease that affects a small number of people but recognized as a global public health priority. Governments worldwide are paying more and more attention to the academical research and drug investment of rare diseases. The conduct of rare disease clin...
Autores principales: | Peng, Ai, Fan, Xue, Zou, Linling, Chen, Huan, Xiang, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173236/ https://www.ncbi.nlm.nih.gov/pubmed/37170366 http://dx.doi.org/10.1186/s13023-023-02713-6 |
Ejemplares similares
-
The Trend of Labor Analgesia in the World and China: A Bibliometric Analysis of Publications in Recent 30 Years
por: Zheng, Huan, et al.
Publicado: (2020) -
Trends of Phase I Clinical Trials of New Drugs in Mainland China Over the Past 10 Years (2011–2020)
por: Chen, Chen, et al.
Publicado: (2021) -
Trends of Clinical Trials for Drug Development in Rare Diseases
por: Sakate, Ryuichi, et al.
Publicado: (2018) -
Trends and Characteristics of New Drug Approvals in China, 2011–2021
por: Su, Ling, et al.
Publicado: (2022) -
10-year trend in quantity and quality of pediatric randomized controlled trials published in mainland China: 2002–2011
por: Yang, Chun-Song, et al.
Publicado: (2013)